Cargando…

Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome

PURPOSE: In selected cases of severe Cushing’s syndrome due to uncontrolled ACTH secretion, bilateral adrenalectomy appears unavoidable. Compared with unilateral adrenalectomy (for adrenal Cushing’s syndrome), bilateral adrenalectomy has a perceived higher perioperative morbidity. The aim of the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Reibetanz, Joachim, Kelm, Matthias, Uttinger, Konstantin L., Reuter, Miriam, Schlegel, Nicolas, Hankir, Mohamed, Wiegering, Verena, Germer, Christoph-Thomas, Fassnacht, Martin, Lock, Johan Friso, Wiegering, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467939/
https://www.ncbi.nlm.nih.gov/pubmed/35633419
http://dx.doi.org/10.1007/s00423-022-02568-8
_version_ 1784788302813986816
author Reibetanz, Joachim
Kelm, Matthias
Uttinger, Konstantin L.
Reuter, Miriam
Schlegel, Nicolas
Hankir, Mohamed
Wiegering, Verena
Germer, Christoph-Thomas
Fassnacht, Martin
Lock, Johan Friso
Wiegering, Armin
author_facet Reibetanz, Joachim
Kelm, Matthias
Uttinger, Konstantin L.
Reuter, Miriam
Schlegel, Nicolas
Hankir, Mohamed
Wiegering, Verena
Germer, Christoph-Thomas
Fassnacht, Martin
Lock, Johan Friso
Wiegering, Armin
author_sort Reibetanz, Joachim
collection PubMed
description PURPOSE: In selected cases of severe Cushing’s syndrome due to uncontrolled ACTH secretion, bilateral adrenalectomy appears unavoidable. Compared with unilateral adrenalectomy (for adrenal Cushing’s syndrome), bilateral adrenalectomy has a perceived higher perioperative morbidity. The aim of the current study was to compare both interventions in endogenous Cushing’s syndrome regarding postoperative outcomes. METHODS: We report a single-center, retrospective cohort study comparing patients with hypercortisolism undergoing bilateral vs. unilateral adrenalectomy during 2008–2021. Patients with adrenal Cushing’s syndrome due to adenoma were compared with patients with ACTH-dependent Cushing’s syndrome (Cushing’s disease and ectopic ACTH production) focusing on postoperative morbidity and mortality as well as long-term survival. RESULTS: Of 83 patients with adrenalectomy for hypercortisolism (65.1% female, median age 53 years), the indication for adrenalectomy was due to adrenal Cushing’s syndrome in 60 patients (72.2%; 59 unilateral and one bilateral), and due to hypercortisolism caused by Cushing’s disease (n = 16) or non-pituitary uncontrolled ACTH secretion of unknown origin (n = 7) (27.7% of all adrenalectomies). Compared with unilateral adrenalectomy (n = 59), patients with bilateral adrenalectomy (n = 24) had a higher rate of severe complications (0% vs. 33%; p < 0.001) and delayed recovery (median: 10.2% vs. 79.2%; p < 0.001). Using the MTL30 marker, patients with bilateral adrenalectomy fared worse than patients after unilateral surgery (MTL30 positive: 7.2% vs. 25.0% p < 0.001). Postoperative mortality was increased in patients with bilateral adrenalectomy (0% vs. 8.3%; p = 0.081). CONCLUSION: While unilateral adrenalectomy for adrenal Cushing’s syndrome represents a safe and definitive therapeutic option, bilateral adrenalectomy to control ACTH-dependent extra-adrenal Cushing’s syndrome or Cushing’s disease is a more complicated intervention with a mortality of nearly 10%.
format Online
Article
Text
id pubmed-9467939
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94679392022-09-14 Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome Reibetanz, Joachim Kelm, Matthias Uttinger, Konstantin L. Reuter, Miriam Schlegel, Nicolas Hankir, Mohamed Wiegering, Verena Germer, Christoph-Thomas Fassnacht, Martin Lock, Johan Friso Wiegering, Armin Langenbecks Arch Surg Original Article PURPOSE: In selected cases of severe Cushing’s syndrome due to uncontrolled ACTH secretion, bilateral adrenalectomy appears unavoidable. Compared with unilateral adrenalectomy (for adrenal Cushing’s syndrome), bilateral adrenalectomy has a perceived higher perioperative morbidity. The aim of the current study was to compare both interventions in endogenous Cushing’s syndrome regarding postoperative outcomes. METHODS: We report a single-center, retrospective cohort study comparing patients with hypercortisolism undergoing bilateral vs. unilateral adrenalectomy during 2008–2021. Patients with adrenal Cushing’s syndrome due to adenoma were compared with patients with ACTH-dependent Cushing’s syndrome (Cushing’s disease and ectopic ACTH production) focusing on postoperative morbidity and mortality as well as long-term survival. RESULTS: Of 83 patients with adrenalectomy for hypercortisolism (65.1% female, median age 53 years), the indication for adrenalectomy was due to adrenal Cushing’s syndrome in 60 patients (72.2%; 59 unilateral and one bilateral), and due to hypercortisolism caused by Cushing’s disease (n = 16) or non-pituitary uncontrolled ACTH secretion of unknown origin (n = 7) (27.7% of all adrenalectomies). Compared with unilateral adrenalectomy (n = 59), patients with bilateral adrenalectomy (n = 24) had a higher rate of severe complications (0% vs. 33%; p < 0.001) and delayed recovery (median: 10.2% vs. 79.2%; p < 0.001). Using the MTL30 marker, patients with bilateral adrenalectomy fared worse than patients after unilateral surgery (MTL30 positive: 7.2% vs. 25.0% p < 0.001). Postoperative mortality was increased in patients with bilateral adrenalectomy (0% vs. 8.3%; p = 0.081). CONCLUSION: While unilateral adrenalectomy for adrenal Cushing’s syndrome represents a safe and definitive therapeutic option, bilateral adrenalectomy to control ACTH-dependent extra-adrenal Cushing’s syndrome or Cushing’s disease is a more complicated intervention with a mortality of nearly 10%. Springer Berlin Heidelberg 2022-05-28 2022 /pmc/articles/PMC9467939/ /pubmed/35633419 http://dx.doi.org/10.1007/s00423-022-02568-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Reibetanz, Joachim
Kelm, Matthias
Uttinger, Konstantin L.
Reuter, Miriam
Schlegel, Nicolas
Hankir, Mohamed
Wiegering, Verena
Germer, Christoph-Thomas
Fassnacht, Martin
Lock, Johan Friso
Wiegering, Armin
Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome
title Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome
title_full Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome
title_fullStr Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome
title_full_unstemmed Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome
title_short Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing’s syndrome
title_sort differences in morbidity and mortality between unilateral adrenalectomy for adrenal cushing’s syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal cushing’s syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467939/
https://www.ncbi.nlm.nih.gov/pubmed/35633419
http://dx.doi.org/10.1007/s00423-022-02568-8
work_keys_str_mv AT reibetanzjoachim differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT kelmmatthias differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT uttingerkonstantinl differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT reutermiriam differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT schlegelnicolas differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT hankirmohamed differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT wiegeringverena differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT germerchristophthomas differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT fassnachtmartin differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT lockjohanfriso differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome
AT wiegeringarmin differencesinmorbidityandmortalitybetweenunilateraladrenalectomyforadrenalcushingssyndromeandbilateraladrenalectomyfortherapyrefractoryextraadrenalcushingssyndrome